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1. Introduction 
Nerve endings and synaptosomal plasma membranes 
have been reported to contain a high concentration f
glycoproteins [1,2] and more recently it has been 
shown that myelin and synaptic membranes contain 
Concanavalin A receptors [3]. Glycopeptides that 
possess concanavalin A receptor activities have been 
recovered from brain tissue by proteolytic treatment 
of defatted tissue and affinity chromatography 
utilizing Concanavalin A-Sepharose [4,5] ; mannose 
rich glycopeptides that bind strongly to Concanavalin 
A are especially enriched in the myelin-rich fraction 
and are present in synaptic plasma membranes. 
Since recent attention has focused on cyclic 3',5'- 
adenosine monophosphate (cAMP) dependent phos- 
phorylation of membrane proteins [6,7], we sought o 
determine whether some of these phosphate-containing, 
membrane-bound proteins were glycoproteins. Several 
phosphoproteins are known to be glycoproteins. 
Rhodopsin [8-11 ] is a glycoprotein that contains a
hexasaccharide; the molecule is phosphorylated by
ATP or GTP in the presence of Mg 2÷. Phosphorylation 
is not stimulated by cyclic nucleotides. Phosvitin, the 
phosphoprotein of hen's egg yolk contains 6.5% 
carbohydrate [ 12]. The heteropolysaccharide 
moiety isolated from phosvitin contained mannose, 
galactose, N-acetylglucosamine a d N-acetylneura- 
minic acid [13]. Phosphate residues were shown to 
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be linked to serine in the polypeptide chain [12,14]. 
Phosphoserine-containing glycoproteins have been 
obtained from bone [15] and teeth [16]. 
In this communication, we describe aphospho- 
glycoprotein that contains aphosphate group which 
is attached to the heteropolysaccharidic side-chain. 
2. Materials and methods 
Male albino rats (Holtzman, Madison, Wis.) were 
injected twice at 24 h intervals with 1 mCi Na2 32po4 
(carrier-free, in 1 ml isotonic saline) intraperitoneally. 
Animals were sacrificed 24 h after the last injection. 
Glycoproteins that contain mannose-rich heteropoly- 
saccharide chains were isolated from the defatted 
brain tissue as described by Susz et al. [17]. Briefly, 
brain was extracted with chloroform-methanol (2:1 
and 1:2, v/v) to remove lipids. The defatted residue 
was dissolved in 5% sodium dodecyl sulfate (SDS) and 
this detergent was exchanged for sodium deoxycholate 
by dialysis. Affinity chromatography on Con A-Sep- 
harose 4B was carried out in the presence of 1% sodium 
deoxycholate. Procedures for polyacrylamide g l 
electrophoresis and gel fdtration of the labeled 
product eluted from Con A-Sepharose are described 
in legends to figs. 1 and 2. Radioactivity on polyacryl- 
amide gels was determined by solubilizing 2 mm 
sections cut from the slab in hydrogen peroxide and 
counted by liquid scintillation in aquasol fluid. 
The phosphorylated glycopeptides were isolated 
from the labeled phosphoglycoprotein starting with 
brain tissue or glycoproteins recovered from the Con 
A Sepharose column. Rats were injected with [a2p] 
PO4 as before and sacrificed 24 h after the last 
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injection. Pooled brain tissue was homogenized in 
cold 10% trichloroacetic a id. The method of Green- 
berg and Rothstein [18] was used to free the 
insoluble material of acid soluble P, lipid P, and 
nucleic acids• The trichloroacetic a id insoluble 
material (up to 10 extractions with 5% trichloroacetic 
acid) was further extracted with chloroform-methanol 
(2:1, 1:2, v/v) to remove residual lipids. Excess 
trichloroacetic a id was removed by extraction with 
ether. Glycopeptides were prepared from the dried 
residue by treatment with papain [5]. Glycosamino- 
glycans and the remaining nucleic acids were removed 
from the soluble material obtained by centrifugation 
by precipitation with cetyl pyridinium chloride [1]. 
The glycopeptides were freed of small molecules by 
exhaustive ultrafdtration on UM-2 membranes u ing 
Amicon (Lexington, Mass.) ultraf'dtration cells, and 
by gel f'dtration on Bio-Gel P-2 columns (5 × 30 cm.). 
The mannose-rich glycopeptides were recovered from 
the glycopeptide preparation by adsorption on Con 
A-Sepharose 4B [4]. After their elution with 2% 
a-methylmannoside, th  material was desalted by 
ultraf'dtration a d gel filtration. The mannose-rich 
glycopeptides were applied to a Dowex l-X8 (chloride) 
column. Neutral mannose-rich glycopeptides were 
washed from the column with water, and the bound 
glycopeptides were eluted with 1 M NaC1. The glyco- 
peptides were then desalted esalted by ultrafdtration 
and gel filtration. 
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Fig.l. Gel filtration of [ 32P]phosphate labeled, Con A-binding glycoproteins that were recovered from a Con A-Sepharose 
column. Sephadex G-50 (fine) columns (1.5 X 90 cm) were pre-equilibrated with 2% sodium dodecyl sulfate• 150 drops (approx. 
5 ml) were collected per tube. The position of the void volume (dextran blue) and the elution of salts (chromate) are indicated by 
the arrows• Radioactivity was determined by counting (Nuclear Chicago Scintillation Counter) of 0.5 ml aliquots from each 
fraction after the addition of 20 ml of Aquasol. Hexose was determined by the phenol-sulfuric acid method [22] using 0.1 ml 
aliquots. Protein was estimated by determining absorbancy at 230 rim. 
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protein serves as a substrate in the membrane-phos- 
phorylation system, the procedure of Johnson et al. 
[6] was used. Synaptosomal fractions from brain 
were recovered by the procedure of Johnson et al. 
[19] and incubated with and without added cyclic 
AMP in the presence of 7-[32P]ATP [6]. After the 
incubation, the Con A-binding glycoproteins were 
isolated from the incubation medium as described 
above by stopping the reaction by heating and the 
addition of 1% SDS. 
3. Results 
Approx. 4% of the total SDS-solubilized protein 
from whole brain was found to bind to Concanavalin 
A-Sepharose, and were eluted with 2% tx-methyl- 
mannoside in 1% sodium deoxycholate. Eight major 
and 4 to 6 minor periodic acid-Schiff positive bands, 
each of which corresponds to protein bands that 
stained with Coomassie blue, were detected by poly- 
acrylamide gel electrophoresis of the Con A-binding 
fraction. The major radioactive peak migrated to a 
position corresponding to an apparent mol. wt. of 
60 000 (standard, bovine serum albumin). The Con 
A-binding glycoproteins were fractionated on 
Sephadex G-50 (1.5 X 90 cm) columns that had been 
equilibrated with 2% SDS. A phosphate-labeled 
glycoprotein fraction was obtained (fig. 1). Upon 
SDS-electrophoresis, this fraction was shown to 
contain a major and two minor bands (fig.2). 
The mannose-rich, Con A-binding glycopeptides 
that were obtained by proteolytic treatment of 
defatted whole brain tissue (or from the Con 
A-binding glycoprotein fraction) were fractionated by 
anion exchange chromatography. Approximately 
80-88% of the glycopeptide-carbohydrate applied 
to Dowex l-X8 (chloride) was washed from the 
column with water. Approximately 12 to 20% of the 
carbohydrate, and all of the 32 p radioactivity was 
adsorbed to the column and eluted with 1 M sodium 
chloride. The molecular weight of the labeled glyco- 
peptide was estimated to be 2200 (gel filtration on 
calibrated Bio-Gel P-4 columns). These acidic glyco- 
peptides did not contain N-acetylneuraminic a id or 
sulfate; the absence of ribose was established by g.l.c. 
Fig.2. Discontinuous polyacrylamide g l electrophoresis of 
the phosphoglycoprotein fraction obtained by gel filtration 
chromatography onG-50 Sephadex (fig.1 .). Approx. 100 ~tg 
protein in 100/~1 was applied to the gel. A discontinuous 
buffer system [17] was used; the gel system consisted of 
three layers, equal in amount, with acrylamide gel concen- 
trations of 4%, 7.5% , and 10%. Electrophoresis was performed 
at room temperature ata constant 2 mA. Proteins were 
stained in a 0.25% Coomassie stain in methanol/acetic a id• 
water'(5/1/4, v/v/v) overnight and destained by diffusion in 
the solvent and 10% acetic acid. The major stained band was 
cut out, dissolved in hydrogen peroxide, and was shown to 
contain radioactive phosphorus by counting. Radioactivity 
in the minor bands only slightly exceeded that of the back- 
ground and identification of these bands as phosphoglyco- 
proteins is uncertain. The origin is at the top of the figure. 
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analysis [5]. The material was devoid of absorbancy 
in ultraviolet light above 230 nm. N.m.r. studies [20] 
revealed the absence of phosphoserine, phospholipid, 
and diester phosphate linkages. None of the label 
could be extracted into an organic phase. Treatment 
of the phosphorylated glycopeptides with leucine 
aminopeptidase did not release radioactive phosphate, 
although amino acids were released by the enzyme. 
Treatment of the phosphorylated glycopeptides with 
ot-mannosidase released mannose, but phosphorylated 
hexose was not liberated. In this regard, Colonna and 
Lampen [21] have reported that phosphomannose 
residues are not suitable substrates for tx-mannosidase. 
The radioactive, Con A-binding glycopeptides were 
hydrolyzed in 0.5 N HC1 for 18 h at 100°C, and the 
hydrolyzate was applied to a column of Dowex 50 
(hydrogen). All of the radioactivity and hexose of the 
original material was washed from the column with 
water. All of the glucosamine was recovered from the 
column by elution with 3 N HCI. The hexose and 
radioactivity that failed to bind to Dowex 50 was 
applied to columns of Dowex l-X8 (chloride). Approx. 
66% of the applied hexose was washed from the 
column with water; elution with 1 M NaC1 provided a
recovery of the remaining 34% of the applied hexose 
and all of the radioactivity. The ratio of hexose to 
glucosamine was 3: I, and this data suggests that one 
of the three hexose units is phosphorylated. 
Synaptosomal fractions that had been incubated 
in the presence and absence of added cAMP and 
~/-[32P]ATP were extracted with SDS and the extracts 
were applied to columns of Con A-Sepharose. No 
radioactivity was found in the glycoproteins that 
bound to Con A; this was true if the incubation was 
carried out in the presence or absence of added cAMP. 
However, radiophosphorus was found in the fraction 
that did not bind to Con A-Sepharose, indicating that 
phosphorylation was active, as reported [6]. Also, it 
was found that the phosphorylated mannose-rich, 
Con A-binding glycopeptides isolated after incubation 
were not radioactive. It was also established that the 
Con A-binding neutral mannose-rich glycopeptides 
did not serve as substrates in the in vitro phosphorylat- 
ing system, with and without added cAMP, of 
Johnson, et al. [6]. It is concluded that the conditions 
of the in vitro phosphorylating system of Johnson et 
al. [6] are not capable of supporting the phosphoryla- 
tion of the phosphoglycoprotein studied here. 
4. Discussion 
The phosphorylated, Con A-binding, mannose rich 
glycopeptides appear to be the only phosphate-con- 
taining heteropolysaccharide chains associated with 
brain glycoproteins [20]. Structural, metabolic, 
subcellular and anatomic distribution studies pertaining 
to these phosphoglycoproteins is under investigation. 
In view of the occurrence of glycoproteins that 
contain phosphoserine r sidues in their polypeptide 
chains, it is suggested that the phosphorylated protein 
studied here be called phosphoglycoproteins,  order 
to distinguish it from the glycophosphoproteins such 
as phosvitin. 
Acknowledgements 
This work was supported in part by a grant from 
the National Science Foundation (GB 33624). 
L. G. Davis was a Research Fellow on a training grant 
from the USPHS (USPMH) awarded to the University 
of Illinois, School of Medicine, Chicago, I11. The work 
described is a part of the dissertation of L. G. Davis 
to be submitted to the Univ. of I11. in partial fulfill- 
ment for therequirements of the PhD degree. 
References 
[1] Brunngraber, E. G. (1970) in: Protein Metabolism of 
the Nervous System (Lajtha, A., ed.) pp. 383-407, 
Plenum Press, New York. 
[2] Breckenridge, W.C., Breckenridge, J. E. and Morgan, 
I. G. (1972) Adv. in Exptl. Biol. and Med. 32, 135-153. 
[3] Matus, A., Peters, S. and Raft, M. C. (1973) Nature, 
New Biol. 244, 278-279. 
[4] Brunngraber, E. G. and Javaid, J. I. (1975) Biochim. 
Biophys. Acta 404, 67-73. 
[5] Javaid, J. I., Hof, H. and Brunngraber, E. G., (1975) 
Biochim. Biophys. Acta 404, 74-82. 
[61 Johnson, E. M., Ueda, T., Maeno, H. and Greengard, P. 
(1972) J. Biol. Chem. 247, 5650-5652. 
[7] Ehrlich, Y. H. and Routtenberg, A. (1974) FEBS Lett. 
45,237-243. 
[8] Heller, J. and Lawrence, M. A. (1970) Biochentistry 9, 
864-868. 
[9] Frank, R. N. and Buzney, S. M. (1975) Biochemistry 14, 
5110-5118. 
[10] Kiihn, H. and Dreyer, W. J. (1972) FEBS Lett. 20, 1-4. 
33 
Volume 65, number 1 FEBS LETTERS May 1976 
[11] Bownds, D., Dawes, J. J., Miller, J. and Stahlman, M., 
(1972) Nature, New Biology, 237,125-126. 
112] Shainkin, R. and Perlmann (1971) J. Biol. Chem. 246, 
2278-2284. 
[13] Shainkin, R. and Perlmann (1971) Arch. Biochem. 
Biophys. 145,693-670. 
[14] Taborsky, G. and Mok, C.-C. (1967) J. Biol. Chem. 242, 
1495-1501. 
[15] Schuster, R. J. and Veis, A. (1964) Biochemistry 3, 
1657-1665. 
[16] Veis, A., Spector, A. R. and Carmichael, D. J. (1969) 
Clin. Orthopaed. and Rel. Res. 66, 188-211. 
17] Susz, J. P., Hof, H. I. and Brunngraber, E. G. (1973) 
FEBS Lett. 32, 289-292. 
18] Greenberg, D. M. and Rothstein, (1957) Meth. Enzymol. 
4, 708-709. 
19] Johnson, E. M., Maeno, H. and Greengard, P. (1971) J. 
J. Biol. Chem. 246, 7731-7739. 
20] Davis, L. G., Costello, A. J. R., Javaid, J. I. and 
Brunngraber, E. G. (1976) FEBS Lett., following paper. 
21 ] Colonna, W. J. and Lampen, J. O. (1974) Biochemistry 
13, 2741-2753. 
22] Dubois, M., GiUes, K. A., Hamilton, J. K., Rebers, P. A. 
and Smith, F. (1956) Anal. Chem. 28,350-356. 
34 
